POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FJ1_A_CTCA222_0 (TETRACYCLINE REPRESSOR PROTEIN CLASS D)	2esp	UBIQUITIN-CONJUGATIN G ENZYME E2 D2 (Homo sapiens)	5 / 12	PRO A  65 THR A  53 VAL A  67 LEU A  86 ILE A 106	None	1.47A	21.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FJ1_A_CTCA222_0 (TETRACYCLINE REPRESSOR PROTEIN CLASS D)	2xdv	MYC-INDUCED NUCLEAR ANTIGEN (Homo sapiens)	5 / 12	SER A 257 PRO A 140 THR A 255 VAL A 254 ILE A 150	None None OGA  A 601 (-3.0A) None None	1.42A	18.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FJ1_A_CTCA222_0 (TETRACYCLINE REPRESSOR PROTEIN CLASS D)	3gov	MASP-1 (Homo sapiens)	5 / 12	PRO A 360 THR A 344 VAL A 327 LEU A 304 SER A 356	None GOL  A   1 (-4.6A) None None None	1.46A	19.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FJ1_A_CTCA222_0 (TETRACYCLINE REPRESSOR PROTEIN CLASS D)	3kij	PROBABLE GLUTATHIONE PEROXIDASE 8 (Homo sapiens)	5 / 12	SER A  99 PHE A 101 PRO A 135 LEU A  62 SER A  70	None	1.00A	19.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FJ1_A_CTCA222_0 (TETRACYCLINE REPRESSOR PROTEIN CLASS D)	4aqb	MANNAN-BINDING LECTIN SERINE PROTEASE 1 (Homo sapiens)	5 / 12	PRO A 360 THR A 344 VAL A 327 LEU A 304 SER A 356	None	1.46A	18.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FJ1_A_CTCA222_0 (TETRACYCLINE REPRESSOR PROTEIN CLASS D)	4boc	DNA-DIRECTED RNA POLYMERASE, MITOCHONDRIAL (Homo sapiens)	5 / 12	PHE A 277 THR A 346 VAL A 347 LEU A 320 ILE A 316	None	1.39A	11.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FJ1_A_CTCA222_0 (TETRACYCLINE REPRESSOR PROTEIN CLASS D)	4fys	AMINOPEPTIDASE N (Homo sapiens)	5 / 12	PHE A 898 THR A 906 VAL A 905 LEU A 845 ILE A 863	None	1.23A	12.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FJ1_A_CTCA222_0 (TETRACYCLINE REPRESSOR PROTEIN CLASS D)	4p4s	INTERFERON-INDUCED GTP-BINDING PROTEIN MX1 (Homo sapiens)	5 / 12	SER A 230 ARG A 208 LEU A 179 ILE A  76 SER A 213	None	1.32A	20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FJ1_A_CTCA222_0 (TETRACYCLINE REPRESSOR PROTEIN CLASS D)	4p4s	INTERFERON-INDUCED GTP-BINDING PROTEIN MX1 (Homo sapiens)	5 / 12	SER B 230 ARG B 208 LEU B 179 ILE B  76 SER B 213	None	1.31A	21.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FJ1_A_CTCA222_0 (TETRACYCLINE REPRESSOR PROTEIN CLASS D)	4xii	CHOLINESTERASE (Homo sapiens)	5 / 12	PHE A 405 PRO A 303 VAL A 233 LEU A 168 SER A 205	None	1.27A	17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FJ1_A_CTCA222_0 (TETRACYCLINE REPRESSOR PROTEIN CLASS D)	4zht	BIFUNCTIONAL UDP-N-ACETYLGLUCOSAM INE 2-EPIMERASE/N-ACETYL MANNOSAMINE KINASE (Homo sapiens)	5 / 12	HIS A 167 SER A 163 HIS A 148 THR A 161 ILE A 178	None	1.45A	19.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FJ1_A_CTCA222_0 (TETRACYCLINE REPRESSOR PROTEIN CLASS D)	5d2n	C25 BETA (Homo sapiens)	5 / 12	SER F 109 PHE F 107 ARG F  36 GLN F   6 LEU F  77	None	1.31A	22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FJ1_A_CTCA222_0 (TETRACYCLINE REPRESSOR PROTEIN CLASS D)	5h07	POLYUBIQUITIN-C (Homo sapiens)	5 / 12	SER A 157 THR A 155 LEU A 115 ILE A 103 SER A 165	None	1.45A	22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_A_CTCA1385_0 (TETX2 PROTEIN)	1z68	FIBROBLAST ACTIVATION PROTEIN, ALPHA SUBUNIT (Homo sapiens)	5 / 10	ASP A 573 PHE A 350 GLY A 349 PRO A 544 GLY A 542	None	1.44A	19.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_A_CTCA1385_0 (TETX2 PROTEIN)	2dw4	LYSINE-SPECIFIC HISTONE DEMETHYLASE 1 (Homo sapiens)	5 / 10	GLN A 554 ARG A 820 GLY A 770 PRO A 808 GLY A 813	None	1.26A	21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_A_CTCA1385_0 (TETX2 PROTEIN)	5l3d	LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A (Homo sapiens)	5 / 10	GLN A 554 ARG A 820 GLY A 770 PRO A 808 GLY A 813	None	1.34A	19.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_B_CTCB1385_0 (TETX2 PROTEIN)	1k4q	GLUTATHIONE REDUCTASE (Homo sapiens)	4 / 8	ARG A 352 PHE A 354 PRO A 150 GLY A 325	None	0.89A	21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_B_CTCB1385_0 (TETX2 PROTEIN)	1u31	NAD(P) TRANSHYDROGENASE, MITOCHONDRIAL (Homo sapiens)	4 / 8	ARG A  89 GLY A  92 PRO A  52 GLY A 128	NDP  A 300 (-3.1A) None None NDP  A 300 (-3.6A)	0.95A	20.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_B_CTCB1385_0 (TETX2 PROTEIN)	2dw4	LYSINE-SPECIFIC HISTONE DEMETHYLASE 1 (Homo sapiens)	5 / 8	GLN A 554 ARG A 820 GLY A 770 PRO A 808 GLY A 813	None	1.27A	21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_B_CTCB1385_0 (TETX2 PROTEIN)	3fed	GLUTAMATE CARBOXYPEPTIDASE III (Homo sapiens)	4 / 8	ARG A  65 GLY A 374 PRO A 138 GLY A 140	None	0.92A	21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_B_CTCB1385_0 (TETX2 PROTEIN)	3p9h	TUMOR SUSCEPTIBILITY GENE 101 PROTEIN (Homo sapiens)	4 / 8	GLY A 107 PRO A  71 GLY A  57 MET A 131	None	0.87A	15.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_B_CTCB1385_0 (TETX2 PROTEIN)	4y85	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 8 (Homo sapiens)	4 / 8	MET A 207 GLY A 210 PRO A 145 GLY A 147	499  A 401 ( 3.7A) 499  A 401 (-3.4A) 499  A 401 (-4.2A) 499  A 401 (-3.3A)	0.77A	21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_B_CTCB1385_0 (TETX2 PROTEIN)	5epg	ALDEHYDE OXIDASE (Homo sapiens)	4 / 8	GLN A 927 PHE A 923 GLY A 924 GLY A 809	None MOS  A3005 (-4.2A) None None	0.70A	14.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_B_CTCB1385_0 (TETX2 PROTEIN)	5l3d	LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A (Homo sapiens)	5 / 8	GLN A 554 ARG A 820 GLY A 770 PRO A 808 GLY A 813	None	1.36A	19.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_B_CTCB1385_0 (TETX2 PROTEIN)	5u3p	DH511.4 FAB HEAVY CHAIN DH511.4 FAB LIGHT CHAIN (Homo sapiens; Homo sapiens)	4 / 8	PHE L  98 GLY L  99 GLY H  60 MET H 100	None	0.71A	19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_B_CTCB1385_0 (TETX2 PROTEIN)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 8	MET A 196 PHE A 199 GLY A 202 GLY A 225	None	0.95A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_C_CTCC1385_0 (TETX2 PROTEIN)	1z68	FIBROBLAST ACTIVATION PROTEIN, ALPHA SUBUNIT (Homo sapiens)	5 / 12	ASP A 573 PHE A 350 GLY A 349 PRO A 544 GLY A 542	None	1.43A	19.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_C_CTCC1385_0 (TETX2 PROTEIN)	2dw4	LYSINE-SPECIFIC HISTONE DEMETHYLASE 1 (Homo sapiens)	5 / 12	GLN A 554 ARG A 820 GLY A 770 PRO A 808 GLY A 813	None	1.27A	21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_C_CTCC1385_0 (TETX2 PROTEIN)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 12	ASP A 778 ARG A 782 GLY A 852 SER A 850 MET A 875	None	1.50A	20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_C_CTCC1385_0 (TETX2 PROTEIN)	3fby	CARTILAGE OLIGOMERIC MATRIX PROTEIN (Homo sapiens)	5 / 12	GLN A 604 GLY A 440 SER A 454 PRO A 690 GLY A 693	None	1.33A	19.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_C_CTCC1385_0 (TETX2 PROTEIN)	4ci8	ECHINODERM MICROTUBULE-ASSOCIAT ED PROTEIN-LIKE 1 (Homo sapiens)	5 / 12	PHE A 464 HIS A 459 GLY A 462 PRO A 505 GLY A 520	None	1.39A	21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_C_CTCC1385_0 (TETX2 PROTEIN)	5l3d	LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A (Homo sapiens)	5 / 12	GLN A 554 ARG A 820 GLY A 770 PRO A 808 GLY A 813	None	1.36A	19.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_D_CTCD1385_0 (TETX2 PROTEIN)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	5 / 10	ASP A 778 ARG A 782 GLY A 852 SER A 850 MET A 875	None	1.49A	20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_0 (TETRACYCLINE DESTRUCTASE TET(50))	1x27	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK (Homo sapiens)	5 / 12	GLU A 125 LEU A 220 THR A 210 GLY A 201 ILE A 183	None	1.09A	19.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_0 (TETRACYCLINE DESTRUCTASE TET(50))	1z2m	INTERFERON, ALPHA-INDUCIBLE PROTEIN (CLONE IFI-15K) (Homo sapiens)	5 / 12	LEU A  54 GLY A  64 PHE A  15 VAL A  17 ILE A  32	None	1.35A	16.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_0 (TETRACYCLINE DESTRUCTASE TET(50))	2g1s	RENIN (Homo sapiens)	5 / 12	VAL A  83 GLY A 124 PHE A  32 VAL A  30 ILE A  19	None	1.07A	21.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_0 (TETRACYCLINE DESTRUCTASE TET(50))	2kxr	TIGHT JUNCTION PROTEIN ZO-1 (Homo sapiens)	5 / 12	PHE A  10 GLY A  23 PHE A  77 VAL A  81 ILE A  28	None	1.17A	13.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_0 (TETRACYCLINE DESTRUCTASE TET(50))	2vc2	INTEGRIN ALPHA-IIB (Homo sapiens)	5 / 12	GLY A 438 PRO A  40 GLY A  52 PHE A  70 ILE A 104	None	1.14A	22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_0 (TETRACYCLINE DESTRUCTASE TET(50))	3eh2	PROTEIN TRANSPORT PROTEIN SEC24C (Homo sapiens)	5 / 12	GLY A 221 PHE A 260 VAL A 291 LEU A 312 VAL A 254	None	1.22A	20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_0 (TETRACYCLINE DESTRUCTASE TET(50))	3ihw	CENTG3 (Homo sapiens)	5 / 12	GLU A 120 THR A 230 GLY A 197 VAL A  94 ILE A 142	None	1.26A	21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_0 (TETRACYCLINE DESTRUCTASE TET(50))	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	5 / 12	GLY A1013 LEU A 503 GLY A 912 GLY A 531 ILE A 598	None	0.86A	19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_0 (TETRACYCLINE DESTRUCTASE TET(50))	3v70	GTPASE IMAP FAMILY MEMBER 1 (Homo sapiens)	5 / 12	GLY A 206 VAL A 178 LEU A 211 GLY A 182 PHE A 188	None	1.05A	21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_0 (TETRACYCLINE DESTRUCTASE TET(50))	4joi	CST COMPLEX SUBUNIT STN1 CST COMPLEX SUBUNIT TEN1 (Homo sapiens; Homo sapiens)	5 / 12	VAL D  93 THR D  25 GLY D  77 GLY A  76 ILE A  31	None	0.90A	14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_0 (TETRACYCLINE DESTRUCTASE TET(50))	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 298 THR A 318 GLY A 317 VAL A 287 ILE A 303	None	1.16A	22.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_0 (TETRACYCLINE DESTRUCTASE TET(50))	4pj1	60 KDA HEAT SHOCK PROTEIN, MITOCHONDRIAL (Homo sapiens)	5 / 12	THR A  91 GLY A  88 GLY A 510 VAL A 124 ILE A 444	ADP  A 601 (-4.0A) ADP  A 601 (-3.5A) None None None	1.15A	25.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_0 (TETRACYCLINE DESTRUCTASE TET(50))	4qxe	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4, LINKER, VARIABLE LYMPHOCYTE RECEPTOR B (Eptatretus burgeri; Homo sapiens)	5 / 12	LEU A 298 THR A 318 GLY A 317 VAL A 287 ILE A 303	None	1.11A	23.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_1 (TETRACYCLINE DESTRUCTASE TET(50))	1jkw	CYCLIN H (Homo sapiens)	4 / 5	ASP A 173 ARG A 177 LEU A 249 MET A 252	None	1.48A	20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_1 (TETRACYCLINE DESTRUCTASE TET(50))	2l7b	APOLIPOPROTEIN E (Homo sapiens)	4 / 5	ASP A 271 ARG A 264 ARG A 260 LEU A  30	None	1.21A	21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_1 (TETRACYCLINE DESTRUCTASE TET(50))	2l7b	APOLIPOPROTEIN E (Homo sapiens)	4 / 5	ASP A 271 ARG A 264 ARG A 260 LEU A  71	None	1.48A	21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_1 (TETRACYCLINE DESTRUCTASE TET(50))	3hzj	RAB GTPASE-ACTIVATING PROTEIN 1-LIKE (Homo sapiens)	4 / 5	ASP A 581 ARG A 584 LEU A 652 MET A 647	None	1.23A	21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_1 (TETRACYCLINE DESTRUCTASE TET(50))	4yub	NICOTINATE PHOSPHORIBOSYLTRANSF ERASE (Homo sapiens)	4 / 5	ASP A  62 ARG A  65 LEU A 170 MET A 168	None	1.32A	20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_1 (TETRACYCLINE DESTRUCTASE TET(50))	6fx0	RETINOIC ACID RECEPTOR GAMMA (Homo sapiens)	4 / 5	ASP A 269 ARG A 387 LEU A 321 MET A 323	None	1.44A	undetectable